Hiroki Takashima
6PUBLICATIONS
9CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Mar 01, 2026
Attenuated Toxicity and Antitoxic Mechanism via Sodium Iodide Symporter Inhibition-Based Tumor-Selective Delivery in Astatine-211 Radioimmunotherapy.Hiroki Takashima, Ryo Tsumura, Yoshikatsu Koga
|Sep 25, 2024
Anti-tissue factor antibody conjugated with monomethyl auristatin E or deruxtecan in pancreatic cancer models.Ryo Tsumura, Takahiro Anzai, Yoshikatsu Koga
|May 14, 2023
Chromatographic Analysis of the N-Glycan Profile on Therapeutic Antibodies Using FcγRIIIa Affinity Column Chromatography.Methanee Hiranyakorn, Shogo Iwamoto, Asako Hoshinoo
|Dec 27, 2022
Tumor Targeting of 211At-Labeled Antibody under Sodium Ascorbate Protection against Radiolysis.Hiroki Takashima, Kazunobu Ohnuki, Shino Manabe
|Jun 06, 2022
Protection from contamination by 211At, an enigmatic but promising alpha-particle-emitting radionuclide.Kazunobu Ohnuki, Mitsuyoshi Yoshimoto, Hiromitsu Haba
|Feb 19, 2021
Radioimmunotherapy with an 211 At-labeled anti-tissue factor antibody protected by sodium ascorbate.Hiroki Takashima, Yoshikatsu Koga, Shino Manabe
Pageof 1
Frequent Collaborators
6 joint publications
Masahiro Yasunaga
5 joint publications
Shino Manabe
2 joint publications
Yoshikatsu Koga
2 joint publications
Ryo Tsumura
1 joint publications
Mitsuyoshi Yoshimoto
1 joint publications
Hiromitsu Haba
1 joint publications
Yasumasa Takenaka
1 joint publications
Hirofumi Fujii
1 joint publications
Yasuhiro Matsumura
